News
22/07/10
DIA Global Forum Article
Check out our article on Clinical Trials in Latin America in the DIA Global Forum Magazine.
31/03/10
Venn Life Sciences completes new funding round and acquires Dutch company
Dublin, Venn Life Sciences, has just completed a significant funding round of over $3 million, to enable it to further accelerate the growth of its business. Venn Life Sciences provides clinical trial services to companies in the pharmaceutical, biotechnology and medical device sectors. Reflecting solid growth achieved by the company over the last two years this financing round was sourced from a select group of private investors with significant expertise and experience in facilitating rapidly growing companies in the Life Sciences arena.
31/03/10
Venn Life Sciences appoints new vp business development
(Dublin, Ireland) Venn Life Sciences would like to announce the appointment of Dale Trask as Vice President Global Business Development, marking an important phase in the company's growth. Mr. Trask brings extensive experience in Clinical Research Organisation (CRO) business development and will be responsible for enhancing Venn's business partnerships, strategic relationships and growth into new markets.
09/03/10
Upcoming conferences
Venn Life Sciences will be attending the following conferences over the coming months
21/01/10
Marlene Llopiz of Venn Life Sciences will be speaking at the MAGI conference in Boston
Meet us at the MAGI conference in Boston May 23-26 2010. Marlene Llopiz of Venn Life Sciences will be speaking on: Working Across Cultures.
15/11/09
Dr Marlene Llopiz – Regional Director for Latin America will present seminar on the H1N1 in Texas
Marlene Llopiz Aviles, M.D. of Venn Life Sciences will present a seminar on the H1N1 flu in Latin America at 4:30 p.m. on Thursday, November 19 at Austin College Texas. The seminar is free and open to the public.